DVT Prophylaxis in Total Joint Reconstruction

Orthopedic Clinics of North America

Volumn 41, Issue 2, 2010, Pages 273-280

  Sheth, Neil P ^a   Lieberman, Jay R ^b   Della Valle, Craig J ^a  

^a RUSH MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Deep venous thrombosis; Prophylaxis; Total joint arthroplasty; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; CEFAMANDOLE; CEPHALOSPORIN; CIMETIDINE; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; FONDAPARINUX; HERBACEOUS AGENT; LEVOTHYROXINE; LOW MOLECULAR WEIGHT HEPARIN; MACROLIDE; METRONIDAZOLE; PHENYTOIN; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; THYROID HORMONE; WARFARIN;

ARTHROPLASTY; BLEEDING; CLINICAL TRIAL; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DRUG COST; GARLIC; HIP ARTHROPLASTY; HOSPITALIZATION; HUMAN; HYPERCOAGULABILITY; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; INTERNATIONAL NORMALIZED RATIO; KNEE ARTHROPLASTY; LENGTH OF STAY; LOW DRUG DOSE; LUNG EMBOLISM; PNEUMATIC COMPRESSION BOOTS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; RISK BENEFIT ANALYSIS; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS PREVENTION; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; ASPIRIN; DRUG INTERACTIONS; HUMANS; INTERNATIONAL NORMALIZED RATIO; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; VENOUS THROMBOSIS; WARFARIN;

EID: 77951897684     PISSN: 00305898     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ocl.2010.02.001     Document Type: Review

References (49)

1. Comp P.C., Spiro T.E., Friedman R.J., et al. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group. J Bone Joint Surg Am 2001, 83(3):336-345.
2. Douketis J.D., Eikelboom J.W., Quinlan D.J., et al. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 2002, 162(13):1465-1471.
3. Brookenthal K.R., Freedman K.B., Lotke P.A., et al. A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty. J Arthroplasty 2001, 13(3):293-300.
4. Freedman K.B., Brookenthal K.R., Fitzgerald R.H., et al. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am 2000, 82(7):929-938.
5. Larson C.M., MacMillan D.P., Lachiewicz P.F. Thromboembolism after total knee arthroplasty: intermittent pneumatic compression and aspirin prophylaxis. J South Orthop Assoc 2001, 10(3):155-163. [discussion: 163].
6. Lieberman J.R., Wollaeger J., Dorey F., et al. The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty. J Bone Joint Surg Am 1997, 79(3):319-325.
7. Nassif J.M., Ritter M.A., Meding J.B., et al. The effect of intraoperative intravenous fixed-dose heparin during total joint arthroplasty on the incidence of fatal pulmonary emboli. J Arthroplasty 2000, 15(1):16-21.
8. Sarmiento A., Goswami A.D. Thromboembolic prophylaxis with use of aspirin, exercise, and graded elastic stockings or intermittent compression devices in patients managed with total hip arthroplasty. J Bone Joint Surg Am 1999, 81(3):339-346.
9. Westrich G.H., Haas S.B., Mosca P., et al. Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty. J Bone Joint Surg Br 2000, 82(6):795-800.
10. SCIP guidelines. Available at: Accessed January 31, 2010. http://www.ashp.org.
11. Deitelzweig D.W., Lin J., Hussein M., et al. Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis?. J Thromb Thrombolysis 2009, [Epub ahead of print].
12. Lieberman J.R., Hsu W.K. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am 2005, 87(9):2097-2112.
13. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133(Suppl 6):381S-453S.
14. Geerts W.H., Heit J.A., Clagett G.P., et al. Prevention of venous thromboembolism. Chest 2001, 119(Suppl 1):132S-175S.
15. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126(Suppl 3):338S-400S.
16. Burnett R.S., Clohisy J.C., Wright R.W., et al. Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty 2007, 22(3):317-324.
17. Parvizi J., Ghanem E., Joshi A., et al. Does " excessive" anticoagulation predispose to periprosthetic infection?. J Arthroplasty 2007, 22(6 Suppl 2):24-28.
18. Johanson N.A., Lachiewicz P.F., Lieberman J.R., et al. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg 2009, 17(3):183-196.
19. Westrich G.H., Sculco T.P. Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg Am 1996, 78(6):826-834.
20. Turpie A.G., Eriksson B.I., Bauer K.A., et al. Fondaparinux. J Am Acad Orthop Surg 2004, 12(6):371-375.
21. Muntz J. Thromboprophylaxis in orthopedic surgery: how long is long enough?. Am J Orthop 2009, 38(8):394-401.
22. Robinson K.S., Anderson D.R., Gross M., et al. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial. Ann Intern Med 1997, 127(6):439-445.
23. Kaempffe F.A., Lifeso R.M., Meinking C. Intermittent pneumatic compression versus coumadin. Prevention of deep vein thrombosis in lower-extremity total joint arthroplasty. Clin Orthop Relat Res 1991, 269:89-97.
24. Fitzgerald R.H., Spiro T.E., Trowbridge A.A., et al. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J Bone Joint Surg Am 2001, 83(6):900-906.
25. Heit J.A., Elliott C.G., Trowbridge A.A., et al. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000, 132(11):853-861.
26. Leclerc J.R., Geerts W.H., Desjardins L., et al. Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin. Ann Intern Med 1996, 124(7):619-626.
27. Hull R., Raskob G., Pineo G., et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993, 329(19):1370-1376.
28. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. J Bone Joint Surg Am 1994, 76(8):1174-1185. RD Heparin Arthroplasty Group.
29. Heit J.A., Berkowitz S.D., Bona R., et al. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group. Thromb Haemost 1997, 77(1):32-38.
30. Mantilla C.B., Horlocker T.T., Schroeder D.R., et al. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology 2003, 9(3):552-560. [discussion: 5A].
31. Sharrock N.E., Gonzalez Della Valle A., Go G., et al. Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res 2008, 466:714-721.
32. Lotke P.A., Lonner J.H. Deep venous thrombosis prophylaxis: better living through chemistry-in opposition. J Arthroplasty 2005, 20(4 Suppl 2):15-17.
33. Lotke P.A., Palevsky H., Keenan A.M., et al. Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop Relat Res 1996, 324:251-258.
34. Weitz J., Michelsen J., Gold K., et al. Effects of intermittent pneumatic calf compression on postoperative thrombin and plasmin activity. Thromb Haemost 1986, 56(2):198-201.
35. Allenby F., Boardman L., Pflug J.J., et al. Effects of external pneumatic intermittent compression on fibrinolysis in man. Lancet 1973, 2(7843):1412-1414.
36. Sharrock N.E., Go G., Mineo R., et al. The hemodynamic and fibrinolytic response to low dose epinephrine and phenylephrine infusions during total hip replacement under epidural anesthesia. Thromb Haemost 1992, 68(4):436-441.
37. Hull R.D., Raskob G.E., Gent M., et al. Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA 1990, 263(17):2313-2317.
38. Gallus A., Raman K., Darby T. Venous thrombosis after elective hip replacement-the influence of preventive intermittent calf compression and of surgical technique. Br J Surg 1983, 7(1):17-19.
39. Francis C.W., Pellegrini V.D., Marder V.J., et al. Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA 1992, 267(21):2911-2915.
40. Bailey J.P., Kruger M.P., Solano F.X., et al. Prospective randomized trial of sequential compression devices vs low-dose warfarin for deep venous thrombosis prophylaxis in total hip arthroplasty. J Arthroplasty 1991, 6(Suppl):S29-S35.
41. Paiement G., Wessinger S.J., Waltman A.C., et al. Low-dose warfarin versus external pneumatic compression for prophylaxis against venous thromboembolism following total hip replacement. J Arthroplasty 1987, 2(1):23-26.
42. Fordyce M.J., Ling R.S. A venous foot pump reduces thrombosis after total hip replacement. J Bone Joint Surg Br 1992, 74(1):45-49.
43. Santori F.S., Vitullo A., Stopponi M., et al. Prophylaxis against deep-vein thrombosis in total hip replacement. Comparison of heparin and foot impulse pump. J Bone Joint Surg Br 1994, 76(4):579-583.
44. Warwick D., Harrison J., Glew D., et al. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial. J Bone Joint Surg Am 1998, 80(8):1158-1166.
45. Haas S.B., Insall J.N., Scuderi G.R., et al. Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg Am 1990, 72(1):27-31.
46. McKenna R., Galante J., Bachmann F., et al. Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br J Surg 1980, 280(6213):514-517.
47. Hull R., Delmore T.J., Hirsh J., et al. Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery. Thromb Res 1979, 16(1-2):37-45.
48. Blanchard J., Meuwly J.Y., Leyvraz P.F., et al. Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system. J Bone Joint Surg Br 1999, 81(4):654-659.
49. Tamir L., Hendel D., Neyman C., et al. Sequential foot compression reduces lower limb swelling and pain after total knee arthroplasty. J Arthroplasty 1999, 14(3):333-338.